Practice point
Posted: Jun 4, 2020
Richard E Bélanger, Christina N Grant; Canadian Paediatric Society, Cannabis Project Advisory Group
Paediatr Child Health 2020, S34–S40. Appendix
While cannabis use among adolescents is frequent in Canada, youth do recognize the potential harms, and increasingly expect knowledgeable health care providers to discuss substance use in everyday practice. This practice point provides sound, evidence-based tools to help health professionals address non-medical (recreational) cannabis use and its related risks. After highlighting how to make the clinical setting a safe space for youth to talk about psychoactive substances, specific strategies for approaching cannabis use in effective, developmentally appropriate ways are described. Consistent with current literature, screening questionnaires to help structure discussion and identify adolescents who may benefit from more specialized interventions are recommended. Because one in six adolescents who experiments with cannabis goes on to misuse it, appraising their willingness to change risky behaviours is a key aspect of care, along with supportive goal-setting and helping families. Recommended resources for practitioners and parents are included.
Keywords: Adolescents, cannabis, counselling, harm reduction, screening
Both parents and adolescents are concerned with the effects and potential harms of cannabis and other psychoactive substances [1][2]. Many adolescents consider health professionals reliable sources of information on psychoactive substances and expect them to talk about usage or risk during health care visits [3]. As facilitators and knowledge brokers, health care providers (HCPs) can effectively engage with youth and families.
This practice point reviews sound, evidence-based tools to help HCPs focus their skills when addressing non-medical (recreational) cannabis use with adolescents in everyday practice. This guidance reflects best practice in adolescent health [4][5] as well as perspectives from Canadian and international experts on adolescent substance use [6][7]. This document also builds on current knowledge of harms associated with adolescent cannabis use, which are described in a Canadian Paediatric Society statement [8] and other resources [9][10]. It also advocates for a coherent, practical approach to counselling.
In a recent Canadian survey, 44% of youth aged 16 to 19 reported using cannabis within the previous year [11], despite its potential adverse effects on brain development and mental health. Now that cannabis use has been legalized in Canada, and with various cannabinoid products and modes of delivery increasingly available, it is critical that HCPs speak to adolescent patients regularly about cannabis [8][12].
Current psychosocial assessment tools such as HEADSSS, SSHADESS [13][14], and THRxEADS [15] all emphasize the importance of routinely addressing psychoactive substances—including cannabis—with young people during medical visits. Unfortunately, only a limited number of clinical encounters with youth include conversations about cannabis [3]. Specific groups, such as adolescents with chronic medical conditions, often go completely unscreened for substance use [16].
Although HCPs may have developed their own approaches to addressing cannabis use, the scientific literature advises using standardized instruments to address and evaluate adolescent cannabis use. As a guide, the authors have adapted a common tool used by physicians for tobacco [17].
The ‘8 As’ (Box 1) allow HCPs to screen for problematic cannabis use and assist in early intervention. The tool also addresses several barriers known to hinder in-clinic efforts to discuss psychoactive substance use with adolescents, such as insufficient time or lack of knowledge [18]. Similar stepwise approaches have gained recognition in effectively addressing substance use among youth [19][20].
History-taking is pivotal when working with adolescents. However, a parent’s presence or involvement can sometimes impede an HCP’s ability to elicit information about risky behaviours, especially when parents are not comfortable with the physician speaking to their child or youth one-on-one. Advise patients and parents that at a certain point (e.g., at age 12, or possibly earlier if developmentally appropriate/relevant), they will start to meet with children alone for at least part of their appointment [4]. Reinforce that meeting alone with adolescents is standard of care. Adolescents need private space and have a right to confidentiality. The primary risk of not ensuring patient confidentiality and privacy is that adolescents will not feel comfortable about confiding or being upfront about their own concerns or behaviours [21].
Be sure to review the definition of confidentiality and how it applies in your jurisdiction. Address any concerns with the patient, and review their understanding of this important issue, clarifying if any help is required [4]. Let them know that you will be asking some personal questions so that you can provide the best care.
Ask the adolescent’s permission to discuss cannabis use and related issues, putting your query into context (Box 2). While requesting permission may seem counterintuitive, it shows respect and invites discussion. You are also letting the adolescent know that they are in control, and that your questions, even when they are personal, serve a specific purpose. For most symptoms reported frequently by youth (e.g., fatigue, sleep problems, low mood), cannabis may be a contributing cause or directly implicated (e.g., when the adolescent is using cannabis to self-medicate (Box 2)). Therefore, even if cannabis use is not the initial cause for consultation, it is a relevant concern and indicates a pertinent question in most situations.
With younger adolescents, consider asking whether (and how) their peers talk about cannabis, or if their friends are “experimenting” with use. Some patients may not know what “cannabis” refers to, either because they are accustomed to more colloquial terms or words that refer to a specific product type or mode of use. It is useful to determine what kind of language the adolescent is using (Box 3). This task can be part of your first round of questioning about substance use.
The literature suggests that adolescents prefer sharing information about their use of psychoactive substances using written or computer-assisted tools as opposed to responding directly to questions from a health professional, so this may be one approach to consider [22]. Regardless of method, asking open-ended questions about frequency of use and dose per use rather than closed questions focused on use or abstinence is more likely to elicit helpful information and to normalize experimentation without minimizing effects [23]. Questionnaires such as the S2BI and the BSTAD [24][25] approach substance use in this way, tracking use over the previous year and including cannabis among other commonly encountered substances.
When young patients have not yet experimented with cannabis, offer positive reinforcement (Box 4). Always ask whether they have questions about cannabis. While youth rely primarily on information online or from peers and parents, they also value health information presented clearly, factually, without bias or judgment. Uncertainty remains around many cannabis-related issues, particularly when several factors have to be taken into account. Harm reduction and promoting safer behaviours should always be at the forefront when counselling young patients. For example, regarding drug-impaired driving, it is crucial to communicate that although there is no consensus about how much cannabis can be consumed before it is unsafe to drive, or how long a driver should wait to drive after consuming cannabis, avoiding the practice at all costs may be life-saving. Alternatives for getting home safe, as a driver or as a passenger, should be explored.
When adolescents report cannabis use, the next step is to screen for problematic use. Problematic use includes a broad range of situations, ranging from conflicts with peers to cannabis use disorder [26]. It is important to inquire about age of onset and/or frequency of use, because these indicators (i.e., using before age 14, and using at least monthly) are strongly associated with adverse health impacts. Physicians must also ask about the possible effects of cannabis use on life domains (e.g., family, social, school, work). Review indicators of impact on physical and mental health (e.g., sleep, cough, stress/anxiety, mood).
One of every six youth who experiments with cannabis will develop problematic use [27]. Several standardized clinical questionnaires can help identify youth who are at risk for adverse effects. Some ask directly about cannabis (e.g., The Cannabis Use Disorder Identification Test – Revised (CUDIT-R) [28] and the Cannabis Abuse Screening Test (CAST) [29]). Others, like the CRAFFT and the Severity of Dependence Scale (SDS), are framed to suit all substances [30][31]. Using a short questionnaire helps HCPs explore the issue efficiently, and responses can be included in the patient’s chart as an objective assessment. The most recent version of the CRAFFT, for example, consists of six questions, is available in several languages, has proven validity with adolescents, and includes vaping among the diverse modes of use [32]. The clear clinical thresholds specific to this questionnaire can guide subsequent discussion with patients.
Using a standardized questionnaire to assess for negative impacts on life avoids the difficulty of establishing a purely clinical diagnosis of problematic substance use [33]. Understanding the products that have been used, the mode and motivation for use, and the context of consumption (as shown in Box 3) can orient counselling and prompt youth to ask for guidance to prevent adverse effects. Choosing a questionnaire that also addresses other substances – particularly tobacco – appears sound, because tobacco use often co-exists with cannabis use [34].
When an adolescent is experiencing negative impacts from cannabis use, or when screening reveals an at-risk profile, the next step should be to appraise willingness to change. Adolescents are often most interested in their physician’s information and support when discussing current cannabis use. One study showed that regardless of whether or not primary care physicians had specialized training to deliver a brief intervention to young patients, simply having a conversation with them about substances was associated with reducing excessive use [35]. For example, HCPs can open the discussion with: “Some adolescents I meet have thought about cutting down on their cannabis use, because while they like the feeling the substance brings, they don’t like (…). Have you ever felt that way? Have you ever thought you might like to cut back?” Box 5 summarizes key elements [36] to include in subsequent discussion.
Box 5. Key elements to include when discussing cannabis use with adolescents
|
When an adolescent asks for help to reduce or stop using, motivational interviewing techniques [6] are the cornerstone therapeutic response and can be initiated immediately. Cannabis is the substance for which young people most commonly consult addiction rehabilitation centres for help [37]. In cases of severe dependency, rehabilitative stays can last several weeks and will integrate several therapeutic components. Unfortunately, compared with other substances, there is no clear evidence to support using medications to manage withdrawal symptoms or help adolescents with cannabis use disorder decrease use or quit [38][39]. Health professionals should be familiar with local support resources and treatment centres. Many treatment options for youth, both outpatient or rehabilitative, are accessed through self-referral only, underscoring the need to assess and support willingness to change. HCPs who need support managing cannabis-dependent youth should reach out to more experienced colleagues, including specialists in adolescent medicine or child and adolescent psychiatry, when available. Drug Free Kids Canada has lists of local resources and centres across Canada (see appendix).
Interventions are only effective when adolescents are willing to voluntarily address substance use and commit to therapy. An adolescent who is reluctant to envision change despite clear evidence of problematic cannabis use is challenging to manage. In this situation, consider these two approaches:
By this stage of management, it is often helpful to include parents, but only after negotiating their involvement with the adolescent. A first step might be to plan a follow-up visit, with the explicit aims of obtaining more specific information, exploring options, and discussing parental involvement. Such a visit should be scheduled within the next few weeks. Some situations are urgent. For example, prompt intervention is warranted when: adolescents are younger; social services are involved; treatment is court-mandated; or when a patient’s social, family, or academic life is being significantly affected by their cannabis use.
When a parent or caregiver’s concern has initiated the consultation, they should be invited to present facts as they perceive them, with a focus on how their child’s or family’s life is being impaired. This conversation can be a springboard for subsequent one-on-one discussions with the adolescent. For example, parents could be asked: “What have you observed that makes you think your child is using cannabis? And, if you think they are using, how does this affect their behaviour at home, at school, or with friends?” Whether a medical encounter starts with or without the youth in question, the aim is to avoid confrontation and judgment. HCPs should explicitly seek and obtain the adolescent’s consent to explore what parents are worried about. “Your parents are concerned that you may be using cannabis. Do you mind if we talk about this?” may be an appropriate way to introduce the subject. The adolescent may not wish to discuss matters further, and they have the right to make that choice. Usually, however, after hearing a parent’s or HCP’s specific health care concerns, adolescents are willing to discuss cannabis use, if only to reassure their parents. Some parents may wish to meet alone with their HCP, in which case the clinician can coach them on how to express concerns to their child in a non-judgmental manner.
Sometimes, parental expectations of the physician’s role need to be reframed. Some experimentation with substance use is common for many youth, and occasional cannabis use is often a transient behaviour [40]. This message can be reassuring for some parents. Parents should also be aware that their own behaviours related to cannabis or other substances may affect their adolescent’s behaviour and perception of harms [41]. There are useful resources for parents and HCPs on how to approach the topic of cannabis with adolescents (see Appendix).
Adolescents frequently use cannabis, which can have many potential adverse effects on both mental and physical health. The HCP’s approach when addressing adolescent cannabis use should be non-judgmental, factual, and – if problematic use is identified – to initiate a mutually agreed-upon therapeutic plan. Evidence suggests that screening for cannabis use with validated tools is the most efficacious method of identifying youth who require intervention. Resources to help parents and additional avenues for HCPs are in the Appendix. Harm reduction and enabling motivation for change are therapeutic cornerstones when assisting youth to overcome problematic cannabis use.
This practice point was reviewed by the Adolescent Health, Community Paediatrics, and Mental Health and Developmental Disabilities Committees of the Canadian Paediatric Society. Special thanks to our colleagues from the Canadian Paediatric Society Cannabis Project Advisory Group, as well as to Francine Charbonneau, Elizabeth Moreau, and Jennie Strickland for their invaluable counsel at diverse stages of the manuscript writing.
Funding: Production of this document has been made possible through a financial contribution from Health Canada. The views expressed herein do not necessarily represent the views of Health Canada.
Potential Conflicts of Interest: Both authors received an honorarium from the Canadian Paediatric Society for their work on the Cannabis Project Advisory Group, which included drafting this practice point. Outside the submitted work, CNG also reports receiving speaker fees from Purdue/Shire, University of Alberta, Queen's University, the Canadian Paediatric Society and the Canadian Association of Paediatric Health Centres. There are no other disclosures. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
CANADIAN PAEDIATRIC SOCIETY CANNABIS PROJECT ADVISORY GROUP
Members: Richard E Bélanger MD (co-Chair), Christina N Grant MD (co-Chair), Michael Hill MD, Ellie Vyver MD, Robert Milin MD (Canadian Academy of Child and Adolescent Psychiatry), Pierre-Paul Tellier MD (College of Family Physicians of Canada)
Principal authors: Richard E Bélanger MD, Christina N Grant MD
Cannabis and Canada’s Children and Youth
Canadian Paediatric Society
This 2017 position statement discusses health impacts of non-medical (recreational) cannabis use and provides recommendations to protect children and adolescents from the harms associated with recreational cannabis use and dependence.
www.cps.ca/en/documents/position/cannabis-children-and-youth
Talking Pot with Youth – A Cannabis Communication Guide for Youth Allies
Canadian Centre on Substance Use and Addiction
https://www.ccsa.ca/talking-pot-youth-cannabis-communication-guide-youth-allies
Counseling Parents and Teens About Marijuana Use in the Era of Legalization of Marijuana
American Academy of Pediatrics
A concise, well-referenced clinical report covering the paediatrician’s role in medical and non-medical cannabis counselling.
https://pediatrics.aappublications.org/content/pediatrics/139/3/e20164069.full.pdf
Canada’s Lower-Risk Cannabis Use Guidelines
Canadian Research Initiative in Substance Misuse (CRISM)
Provides 10 recommendations for ways to use cannabis more safely.
https://www.camh.ca/-/media/files/pdfs---reports-and-books---research/canadas-lower-risk-guidelines-cannabis-pdf.pdf
Non-Medical Cannabis Resource (for providers)
Centre for Effective Practice
Helps primary care providers discuss non-medical cannabis with patients. Includes sections on screening, potential harms, and tips for harm reduction.
https://cep.health/media/uploaded/CEP_Non-Medical_Cannabis_Resource_2018.pdf
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
National Academies of Science, Engineering and Medicine (U.S.)
Not specific to adolescents and children, but information is broadly insightful.
https://www.ncbi.nlm.nih.gov/books/NBK423845/
Resources in your region
Drug Free Kids Canada
https://www.drugfreekidscanada.org/treatment-recovery/get-help-in-your-region/
Cannabis: What parents need to know
Canadian Paediatric Society
www.caringforkids.cps.ca/handouts/marijuana-what-parents-need-to-know
Cannabis Talk-Kit: Know How to Talk With Your Teen
Drug Free Kids Canada
https://www.drugfreekidscanada.org/wp-content/uploads/pdf/Cannabis-Talk-Kit_EN.pdf
Cannabis Products, Including Edibles
Drug Free Kids Canada
https://www.drugfreekidscanada.org/wp-content/uploads/2020/01/DFK_Info_Cannabis_FINAL.pdf
Cannabis: What Parents/Guardians and Caregivers Need to Know
School Mental Health Ontario/The Centre for Addiction and Mental Health
https://smho-smso.ca/wp-content/uploads/2019/08/Cannabis-Parent-Infosheet.pdf
Cannabis Use and Youth: A parent’s guide
B.C. Partners for Mental Health and Substance Use Information
Covers terminology, potential harms, common claims, and ways to interact with youth.
www.heretohelp.bc.ca/workbook/cannabis-use-and-youth-a-parents-guide
Do You Speak Cannabis?
Government of Quebec
Information and talking points to allow parents to broach the subject of cannabis with their child.
https://publications.msss.gouv.qc.ca/msss/fichiers/2018/18-236-06A.pdf
Thinking about using cannabis while parenting?
Health Canada
www.canada.ca/en/health-canada/services/drugs-medication/cannabis/health-effects/parents.html
Marijuana: Facts Parents Need to Know
National Institute on Drug Abuse (U.S.)
https://d14rmgtrwzf5a.cloudfront.net/sites/default/files/mj_parents_facts_brochure.pdf
Cannabis: Important things to know
Kids Help Phone
https://kidshelpphone.ca/get-info/cannabis-important-things-know/
The Blunt Truth: Useful tips about safer ways to use cannabis
Canadian Research Initiative in Substance Misuse, CAMH
http://crismontario.ca/Pages/LRCUG.YouthBrochure.English.Final.pdf
Cannabis: Inhalation vs Ingestion - What happens in the body?
Drug Free Kids Canada
https://www.drugfreekidscanada.org/wp-content/uploads/2020/02/DFK_Cannabis_1Pg_FINAL.pdf
Learn about cannabis
First Nations Health Authority
https://www.fnha.ca/what-we-do/mental-wellness-and-substance-use/non-medical-cannabis-information
Disclaimer: The recommendations in this position statement do not indicate an exclusive course of treatment or procedure to be followed. Variations, taking into account individual circumstances, may be appropriate. Internet addresses are current at time of publication.
Last updated: Feb 16, 2021